Global Tacrolimus Ointment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tacrolimus Ointment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Tacrolimus ointment is a topical drug (a drug that is applied to the skin) that is used for the treatment of atopic dermatitis (eczema). Atopic dermatitis is a chronic (long-lasting) disease of skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. The inflammation is caused by activation of the immune system though the reason for the activation is unknown. Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment was approved for the treatment of atopic dermatitis in December 2000.
Tacrolimus Ointment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tacrolimus Ointment market is projected to reach US$ 543.5 million in 2029, increasing from US$ 365 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Kids are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tacrolimus Ointment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Tacrolimus Ointment key manufacturers include LEO Pharma, Sandoz, Glenmark, Zhejiang Wansheng Pharmaceutical, North China Pharmaceutical Company, Humanwell, Sichuan Med-Shine Pharmaceutical and IVA HEALTHCARE, etc. LEO Pharma, Sandoz, Glenmark are top 3 players and held % sales share in total in 2022.
Tacrolimus Ointment can be divided into Ointment 0.1% and Ointment 0.03%, etc. Ointment 0.1% is the mainstream product in the market, accounting for % sales share globally in 2022.
Tacrolimus Ointment is widely used in various fields, such as Adult and Kids, etc. Adult provides greatest supports to the Tacrolimus Ointment industry development. In 2022, global % sales of Tacrolimus Ointment went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tacrolimus Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Segment by Type
Ointment 0.1%
Ointment 0.03%
Adult
Kids
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tacrolimus Ointment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tacrolimus Ointment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tacrolimus Ointment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tacrolimus Ointment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tacrolimus Ointment introduction, etc. Tacrolimus Ointment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Tacrolimus Ointment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Tacrolimus Ointment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tacrolimus Ointment market is projected to reach US$ 543.5 million in 2029, increasing from US$ 365 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Kids are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tacrolimus Ointment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Tacrolimus Ointment key manufacturers include LEO Pharma, Sandoz, Glenmark, Zhejiang Wansheng Pharmaceutical, North China Pharmaceutical Company, Humanwell, Sichuan Med-Shine Pharmaceutical and IVA HEALTHCARE, etc. LEO Pharma, Sandoz, Glenmark are top 3 players and held % sales share in total in 2022.
Tacrolimus Ointment can be divided into Ointment 0.1% and Ointment 0.03%, etc. Ointment 0.1% is the mainstream product in the market, accounting for % sales share globally in 2022.
Tacrolimus Ointment is widely used in various fields, such as Adult and Kids, etc. Adult provides greatest supports to the Tacrolimus Ointment industry development. In 2022, global % sales of Tacrolimus Ointment went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tacrolimus Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Segment by Type
Ointment 0.1%
Ointment 0.03%
Segment by Application
Adult
Kids
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tacrolimus Ointment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tacrolimus Ointment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tacrolimus Ointment industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tacrolimus Ointment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tacrolimus Ointment introduction, etc. Tacrolimus Ointment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Tacrolimus Ointment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices